| Patient | Benny Leonard |
|---|---|
| Date of birth | 1976-04-07 |
| Identifiers | MRN HR-BX008-SYN; SSN (made up) 000-08-4106 |
| Document date | 2026-05-12 |
| Author | Miriam Okafor-Rosenthal, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
A 50-year-old professional boxing referee and boxing instructor with newly found stage 2 hypertension, left ventricular hypertrophy by voltage on the ECG, and two months of breathlessness and chest tightness late in long nights of refereeing in hot arenas. Please evaluate the symptoms and the hypertrophy, advise on his coronary and sudden cardiac death risk, and say whether and how he can keep refereeing. [S]
Urgency: Soon, within two weeks; he is refereeing only short undercards until seen. [S]
Questions for the consultant:
Former world lightweight champion; referees whole cards of six to eight bouts several nights a week and teaches boxing. For about two months, late in long cards in hot arenas, breathlessness and tightness across the chest when moving quickly, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling. Found at his yearly license examination to have blood pressure 164/100 and 160/98 mmHg, untreated. ECG today: sinus rhythm, left ventricular hypertrophy by voltage (Sokolow-Lyon 38 mm, Cornell 24 mm) with mild lateral T-wave flattening, QTc 418 ms, no Q waves or pre-excitation. Laboratory tests today: creatinine 0.98 mg/dL, potassium 4.1 mmol/L, HbA1c 5.5%, TSH 1.9, urine albumin-to-creatinine ratio 22 mg/g, total cholesterol 234, LDL 160, HDL 44 mg/dL, lipoprotein(a) 42 nmol/L. Never smoked; little alcohol. Family history not known. Started today on losartan 50 mg with hydrochlorothiazide 12.5 mg with home monitoring. Money is tight since he lost his savings years ago, and he is anxious about his license; please favor low-cost generic medicines [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morning | One tablet each morning | Oral route | 2026-05-12 to 2026-06-30 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultation | active | confirmed | R06.09 | S — Synthetic presenting problem anchored to his documented work as a referee; superseded at the consultation when stress testing showed no ischemia and the symptom was attributed to hypertensive heart disease. |
| Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to follow | active | confirmed | I10 | S — Synthetic diagnosis at intake; reclassified as hypertensive heart disease after the echocardiogram at the consultation. |
| Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetes | active | confirmed | E78.00 | S — Synthetic diagnosis at intake. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-12 | Body height | 165 | cm | S |
| 2026-05-12 | Body weight | 74.6 | kg | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 27.4 | kg/m2 | S |
| 2026-05-12 | Systolic blood pressure | 164 | mm[Hg] | S |
| 2026-05-12 | Diastolic blood pressure | 100 | mm[Hg] | S |
| 2026-05-12 | Heart rate | 78 | /min | S |
| 2026-05-12 | Respiratory rate | 16 | /min | S |
| 2026-05-12 | Body temperature | 36.7 | Cel | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-12 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-146 mmol/L | Normal | S |
| 2026-05-12 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 2026-05-12 | Urea nitrogen [Mass/volume] in Serum or Plasma | 15 | mg/dL | 7-25 mg/dL | Normal | S |
| 2026-05-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 2026-05-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 93 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-05-12 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 65-99 mg/dL | Normal | S |
| 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2026-05-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| 2026-05-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 2026-05-12 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 2026-05-12 | Albumin/Creatinine [Mass Ratio] in Urine | 22 | mg/g{creat} | <=29 mg/g{creat} | Normal | S |
| 2026-05-12 | Cholesterol [Mass/volume] in Serum or Plasma | 234 | mg/dL | <=199 mg/dL | High | S |
| 2026-05-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-05-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 160 | mg/dL | <=99 mg/dL | High | S |
| 2026-05-12 | Triglyceride [Mass/volume] in Serum or Plasma | 150 | mg/dL | <=149 mg/dL | High | S |
| 2026-05-12 | Lipoprotein a [Moles/volume] in Serum or Plasma | 42 | nmol/L | <=124 nmol/L | Normal | S |
| 2026-05-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 2026-05-12 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | {score} | S | ||
| 2026-05-12 | Total score [AUDIT-C] | 2 | {score} | S |